Macular Degeneration Treatment Market Report

Global and Region Macular Degeneration Treatment Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：143
  • REPORT CODE：GMM996098
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Macular degeneration, also known as age-related macular degeneration (AMD or ARMD), is a medical condition which may result in blurred or no vision in the center of the visual field. Early on there are often no symptoms. Over time, however, some people experience a gradual worsening of vision that may affect one or both eyes. While it does not result in complete blindness, loss of central vision can make it hard to recognize faces, drive, read, or perform other activities of daily life. Visual hallucinations may also occur but these do not represent a mental illness.

    The report details the trend, potential and market size of Macular Degeneration Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Macular Degeneration Treatmentmarket, defines the market attractiveness level of Macular Degeneration Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Macular Degeneration Treatment industry, describes the types of Macular Degeneration Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Macular Degeneration Treatment market and the development prospects and opportunities of Macular Degeneration Treatment industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Macular Degeneration Treatment market in Chapter 13.

    By Player:

    • Novartis AG

    • Pfizer Inc

    • F Hoffmann-La Roche AG

    • Bausch Health Companies Inc

    • Regeneron

    By Type:

    • Lucentis

    • Eylea

    • Avastin

    • Others

    By End-User:

    • Hospitals

    • Eye Clinics

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Macular Degeneration Treatment Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Macular Degeneration Treatment Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Macular Degeneration Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Macular Degeneration Treatment Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Macular Degeneration Treatment Market Analysis and Outlook to 2022

    • 7.1 Global Macular Degeneration Treatment Consumption (2017-2022)

    • 7.2 United States Macular Degeneration Treatment Consumption (2017-2022)

    • 7.3 Europe Macular Degeneration Treatment Consumption (2017-2022)

    • 7.4 China Macular Degeneration Treatment Consumption (2017-2022)

    • 7.5 Japan Macular Degeneration Treatment Consumption (2017-2022)

    • 7.6 India Macular Degeneration Treatment Consumption (2017-2022)

    • 7.7 South Korea Macular Degeneration Treatment Consumption (2017-2022)

    8 Region and Country-wise Macular Degeneration Treatment Market Analysis and Outlook to 2028

    • 8.1 Global Macular Degeneration Treatment Consumption Forecast (2022-2028)

    • 8.2 United States Macular Degeneration Treatment Consumption Forecast (2022-2028)

    • 8.3 Europe Macular Degeneration Treatment Consumption Forecast (2022-2028)

    • 8.4 China Macular Degeneration Treatment Consumption Forecast (2022-2028)

    • 8.5 Japan Macular Degeneration Treatment Consumption Forecast (2022-2028)

    • 8.6 India Macular Degeneration Treatment Consumption Forecast (2022-2028)

    • 8.7 South Korea Macular Degeneration Treatment Consumption Forecast (2022-2028)

    9 Global Macular Degeneration Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Macular Degeneration Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Lucentis Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Eylea Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Avastin Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Macular Degeneration Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Eye Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Macular Degeneration Treatment Market Outlook by Types and Applications to 2028

    • 10.1 Global Macular Degeneration Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Lucentis Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Eylea Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Avastin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Macular Degeneration Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Eye Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Macular Degeneration Treatment Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Macular Degeneration Treatment Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Macular Degeneration Treatment Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Macular Degeneration Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Macular Degeneration Treatment Market Competitive Analysis

    • 14.1 Novartis AG

      • 14.1.1 Novartis AG Company Details

      • 14.1.2 Novartis AG Macular Degeneration Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Novartis AG Macular Degeneration Treatment Product and Service

    • 14.2 Pfizer Inc

      • 14.2.1 Pfizer Inc Company Details

      • 14.2.2 Pfizer Inc Macular Degeneration Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Pfizer Inc Macular Degeneration Treatment Product and Service

    • 14.3 F Hoffmann-La Roche AG

      • 14.3.1 F Hoffmann-La Roche AG Company Details

      • 14.3.2 F Hoffmann-La Roche AG Macular Degeneration Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 F Hoffmann-La Roche AG Macular Degeneration Treatment Product and Service

    • 14.4 Bausch Health Companies Inc

      • 14.4.1 Bausch Health Companies Inc Company Details

      • 14.4.2 Bausch Health Companies Inc Macular Degeneration Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Bausch Health Companies Inc Macular Degeneration Treatment Product and Service

    • 14.5 Regeneron

      • 14.5.1 Regeneron Company Details

      • 14.5.2 Regeneron Macular Degeneration Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Regeneron Macular Degeneration Treatment Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Macular Degeneration Treatment

    • Figure Macular Degeneration Treatment Picture

    • Table Global Macular Degeneration Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Macular Degeneration Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Macular Degeneration Treatment Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Macular Degeneration Treatment Consumption by Country (2017-2022)

    • Figure United States Macular Degeneration Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Macular Degeneration Treatment Consumption and Growth Rate (2017-2022)

    • Figure China Macular Degeneration Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Macular Degeneration Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Macular Degeneration Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Macular Degeneration Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Macular Degeneration Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Macular Degeneration Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Macular Degeneration Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Macular Degeneration Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Macular Degeneration Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Macular Degeneration Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Macular Degeneration Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lucentis Consumption and Growth Rate (2017-2022)

    • Figure Global Eylea Consumption and Growth Rate (2017-2022)

    • Figure Global Avastin Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Eye Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Lucentis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Eylea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Avastin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Eye Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Macular Degeneration Treatment Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Macular Degeneration Treatment Export by Region (Top 5 Countries) (2017-2028)

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Macular Degeneration Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Macular Degeneration Treatment Product and Service

    • Table Pfizer Inc (Foundation Year, Company Profile and etc.)

    • Table Pfizer Inc Macular Degeneration Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Macular Degeneration Treatment Product and Service

    • Table F Hoffmann-La Roche AG (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche AG Macular Degeneration Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche AG Macular Degeneration Treatment Product and Service

    • Table Bausch Health Companies Inc (Foundation Year, Company Profile and etc.)

    • Table Bausch Health Companies Inc Macular Degeneration Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bausch Health Companies Inc Macular Degeneration Treatment Product and Service

    • Table Regeneron (Foundation Year, Company Profile and etc.)

    • Table Regeneron Macular Degeneration Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Regeneron Macular Degeneration Treatment Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US